NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 20, 2026 — Hong Kong's GFS hosts inaugural ISERAS symposium on emergency response and aeromedical services, bringing together over 230 experts from 70+ institutions to foster international collaboration.
June 19, 2026 — VERAXA Biotech releases new in vitro data for its BiTAC-ADC platform, showing tumor-specific killing of breast cancer cells with reduced toxicity. The company seeks partnerships at BIO 2026.
June 19, 2026 — Discover if dental implants are affordable with this practical guide. Learn about costs, long-term value, and ways to save on treatment from Affordable Dentist Near me of Denton.
June 19, 2026 — LakeShore Biopharma shareholders approve merger with Oceanpine Skyline Inc., moving toward privatization. The vaccine developer will delist from OTC Markets, focusing on PIKA® platform for infectious diseases.
June 19, 2026 — CCHR review finds psychiatric hospitals fail to warn of ECT risks like memory loss and brain damage, despite FDA requirements. Calls for government investigation and ban.
June 19, 2026 — Creative Biolabs launches one-stop antisense oligonucleotide development services to overcome delivery and stability challenges, accelerating ASO therapeutics from design to preclinical validation.
June 19, 2026 — Burton Law Firm discusses North Carolina's House Bill 67, a healthcare workforce reform that expands access to physicians and PAs, benefiting personal injury clients.
June 18, 2026 — Voyageur Pharmaceuticals evaluates three U.S. sites for an integrated iodine and barium contrast media facility in Oklahoma and Texas, aiming for cost leadership and supply security.
June 18, 2026 — BioUtah and partners host Utah Pavilion at BIO International Convention, showcasing the state's fastest-growing life sciences sector. Learn about collaborations, investment opportunities, and Utah's bio ecosystem.
June 18, 2026 — Cardio Diagnostics Holdings (CDIO) leverages AI, epigenetics, and genetics for personalized cardiovascular care, aiming to prevent heart disease through predictive precision medicine.
June 18, 2026 — Onco-Innovations develops PNKP inhibitors and AI-driven precision oncology. Learn how this clinical-stage company targets DNA repair pathways to fight cancer.
June 18, 2026 — Earth Science Tech (ETST) reports fiscal 2026 results: revenue $35.7M (+8%), net income $3.6M (+11%), asset growth 27%. Shares repurchased. Integrated healthcare platform expands.
June 18, 2026 — Medicaid work requirements final rules: CMS issues new eligibility criteria. Enrollees must comply to retain coverage. Impact on healthcare stakeholders like Astiva Health. Read more at BioMedWire.
June 18, 2026 — VERAXA Biotech announces in vitro proof-of-concept for BiTAC-ADC platform, targeting breast cancer with tumor-restricted activation. Data shows dose-dependent killing of 3D spheroids.
June 18, 2026 — iMD Companies (OTC: ICBU) is in advanced due diligence for a mining acquisition and active negotiations for a medical health company, aiming to boost growth and shareholder value.
June 18, 2026 — Kiora Pharmaceuticals reports preclinical data showing KIO-300 suppresses seizure activity in an epilepsy model, presented at the Epilepsy Foundation Pipeline Conference. Learn about the dual potential of this ion channel modulator.
June 18, 2026 — Alfa Cytology expands radiopharmaceutical development services by integrating custom radiolabeling for ADCs and targeted radiopharmaceuticals with physicochemical characterization CRO, supporting precision medicine advancement.
June 18, 2026 — Copper infused sheets market to hit $609.9M by 2036, driven by antimicrobial bedding demand. Key players, textile-based sheets, and healthcare applications highlighted.
June 18, 2026 — Probiotic Skincare Market to grow from $728M in 2025 to $1.47B by 2036 at 6.6% CAGR. Fact.MR report highlights microbiome science, clean beauty, and Asia-Pacific growth.
June 18, 2026 — Global AML therapeutics market to grow from $3.8B in 2025 to $10.1B by 2036 at 9.2% CAGR. Targeted therapies lead with 36% share. Key players: AbbVie, Roche, Astellas. India fastest-growing at 11.8% CAGR.